Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Vital Therapies abandons liver cell therapy, loses 80% share price

This week in cell therapy: Cell and Gene Therapy Catapult is granted MHRA manufacturing licenses and baby teeth stem cells shown to regrow damaged dental tissue.

Go to the profile of RegMedNet
Sep 13, 2018

Please sign in or register for FREE

No comments yet.